Company Filing History:
Years Active: 2012
Title: Innovator Kevin J. McDonnell: Pioneering Tissue Targeting Domains
Introduction: Kevin J. McDonnell, an accomplished inventor based in Little Neck, NY, has made significant strides in the field of biomedicine. His innovative thinking has led to the development of a patent that holds the potential to enhance the efficacy of targeted therapies in treating tumors.
Latest Patents: McDonnell's notable patent, titled "Method for identifying targeting domains and methods and compositions comprising the same," focuses on a revolutionary approach to identifying tissue targeting domains. This invention outlines methods for pinpointing a polynucleotide that encodes a targeting domain, designed to direct tumor cell localization to secondary sites. The implications of this patent extend to various methods of utilizing the polynucleotide and its corresponding polypeptide or fragments, potentially impacting future treatments for cancer patients.
Career Highlights: Kevin J. McDonnell currently contributes his expertise to Georgetown University, where he is involved in cutting-edge research initiatives. His work primarily revolves around improving therapeutic strategies for cancer treatment, showcasing his commitment to advancing the medical field through innovation.
Collaborations: McDonnell has collaborated with esteemed colleagues Anton Wellstein and Justinian R. Ngaiza. Together, they work towards enhancing understanding and applications of targeting domains, with aspirations to translate their findings into practical solutions for treating complex diseases.
Conclusion: Kevin J. McDonnell stands out as a prominent figure in the realm of biomedical innovation. His patent on targeted domain identification not only reflects his dedication to advancing therapeutic methods but also embodies the spirit of collaboration within the research community. As he continues his work at Georgetown University, the implications of his contributions are poised to extend far beyond academia, promising new possibilities for patient care in oncology.